Sun Pharmaceutical Industries Ltd.

Anti Retro Viral Medications

We offer a wide range of WHO prequalified ARV medicines. Improving access and affordability is our key objective. We supply ARVs to various National AIDS treatment programs in Africa. In 2004, we signed up with the Clinton Health Access Initiative (CHAI) to help reduce the cost of the triple drug cocktail for consortium partners in Africa and other countries.  Our portfolio comprises bio-equivalent ARV medicines and Active Pharmaceutical Ingredients (API) manufactured at our state-of-the-art WHO prequalified manufacturing facilities in India, a PIC/S approved manufacturing facility in South Africa and a facility in Russia. Indeed, with several first-line and second line Highly Active Antiretroviral Therapy (HAART) regimens in our portfolio, we hope to contribute significantly to combating HIV/AIDS.